Myeloproliferative disorders require longterm monitoring from "summary" of Hematology Board Review by Francis P. Worden, MD,Rami N. Khoriaty, MD,Kathleen A. Cooney, MD,Michael W. Deininger, MD, PhD
Myeloproliferative disorders are chronic hematologic conditions characterized by abnormal proliferation of blood cells in the bone marrow. These disorders include polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Patients with myeloproliferative disorders require long-term monitoring due to the potential for disease progression and development of serious complications. Regular monitoring is essential to assess disease progression, response to treatment, and the development of complications such as thrombosis or transformation to acute leukemia. Patients with myeloproliferative disorders should undergo routine blood tests, including complete blood counts and peripheral blood smears, to monitor for changes in blood cell counts and morphology. In addition to blood tests, other diagnostic studies such as bone marrow biopsies ...
Similar Posts
Hormones in certain foods can promote cancer growth
Hormones in certain foods can promote the growth of cancer cells. This concept is crucial to understand the impact of our diet ...
Cancer prevention is key to reducing the disease burden
Cancer prevention stands as a sentinel task in the fight against a disease that has plagued humanity for centuries. The idea th...
Bone marrow transplant is a potentially curative option
Bone marrow transplant is a potential curative option for certain hematologic malignancies and nonmalignant disorders. This pro...
Monitoring response to treatment is essential for outcomes
The importance of monitoring response to treatment cannot be overstated in the field of hematology. It is a critical aspect of ...